Current Price Action and Market Context
As of 5 Aug 2026, Syngene International Ltd closed at ₹407.30, marking a modest increase of 1.46% from the previous close of ₹401.45. The intraday range saw a low of ₹399.90 and a high of ₹412.20, indicating some volatility but limited upward momentum. The stock remains significantly below its 52-week high of ₹709.30, while hovering just above its 52-week low of ₹375.50, underscoring a challenging price environment.
Comparatively, the Sensex has outperformed Syngene over multiple time horizons. Year-to-date, Syngene has declined by 37.43%, whereas the Sensex has gained 7.97%. Over the past year, the stock has fallen 42.24%, contrasting with a modest 3.20% decline in the Sensex. Even over a five-year span, Syngene’s return of -34.38% starkly contrasts with the Sensex’s robust 44.25% gain, highlighting the stock’s underperformance within the broader market context.
Technical Trend Analysis: Mixed Signals
The technical trend for Syngene has shifted from outright bearish to mildly bearish, signalling a tentative attempt at stabilisation but no clear reversal. The daily moving averages remain bearish, indicating that short-term momentum is still weak and the stock is trading below key average price levels.
On the weekly chart, the Moving Average Convergence Divergence (MACD) indicator has turned mildly bullish, suggesting some positive momentum building in the near term. However, the monthly MACD remains bearish, reflecting persistent downward pressure over a longer timeframe. This divergence between weekly and monthly MACD readings points to a potential short-term rally within an overall bearish trend.
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no definitive signal, hovering in neutral territory. This lack of momentum confirmation implies that the stock is neither overbought nor oversold, leaving room for either direction but no clear bias.
Bollinger Bands and KST Indicators
Bollinger Bands on both weekly and monthly timeframes are mildly bearish, indicating that price volatility remains subdued but with a downward bias. The stock price is closer to the lower band, which often suggests potential support but also signals caution as downside risk persists.
The Know Sure Thing (KST) indicator presents a similar mixed picture: mildly bullish on the weekly scale but bearish on the monthly. This again highlights the short-term technical attempts at recovery amid a longer-term downtrend.
Volume and Dow Theory Signals
On-Balance Volume (OBV) readings show no clear trend on either weekly or monthly charts, suggesting that volume is not confirming price movements decisively. Similarly, Dow Theory analysis indicates no established trend on weekly or monthly timeframes, reinforcing the notion of technical uncertainty and lack of conviction among market participants.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Mojo Score and Rating Implications
MarketsMOJO assigns Syngene International Ltd a Mojo Score of 24.0, categorising it as a Strong Sell. This represents a downgrade from the previous Sell rating on 30 Jul 2026, reflecting deteriorating fundamentals and technical outlook. The small-cap status of the company further accentuates risk factors, as smaller companies tend to exhibit higher volatility and lower liquidity.
The downgrade is consistent with the technical indicators showing persistent bearishness on longer timeframes despite some short-term bullish signals. Investors should be cautious given the stock’s weak relative performance and the absence of strong volume confirmation.
Long-Term Performance and Sector Context
Over the past decade, Syngene has delivered a 98.15% return, which, while positive, pales in comparison to the Sensex’s 182.99% gain. This underperformance is notable given the company’s position in the Healthcare Services sector, which has generally been resilient. The sector’s defensive qualities have not translated into outperformance for Syngene, suggesting company-specific challenges.
Investors analysing Syngene should weigh the technical signals alongside fundamental factors, including sector dynamics and company-specific developments, before making investment decisions.
Syngene International Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Syngene International Ltd’s technical indicators present a cautious picture. While weekly MACD and KST suggest mild bullish momentum, the dominant monthly signals remain bearish, and daily moving averages confirm ongoing weakness. The absence of clear volume support and neutral RSI readings add to the uncertainty.
Given the strong sell rating and the stock’s underperformance relative to the Sensex and sector peers, investors should approach with caution. Short-term traders might find opportunities in the mild weekly bullish signals, but longer-term investors should consider the prevailing downtrend and fundamental challenges.
Monitoring key technical levels, such as the 52-week low of ₹375.50 and resistance near the daily highs around ₹412, will be critical for assessing any potential trend reversals. Until more decisive signals emerge, the stock’s outlook remains guarded.
Summary
In summary, Syngene International Ltd is navigating a complex technical landscape with mixed momentum signals. The downgrade to a Strong Sell rating by MarketsMOJO reflects the stock’s deteriorating fundamentals and technical outlook. While short-term indicators hint at mild bullishness, the dominant monthly trends and moving averages remain bearish. Investors should weigh these factors carefully and consider alternative opportunities within the Healthcare Services sector.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
